Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hepatitis C

Free Subscription Articles published in J Gastroenterol Retrieve available abstracts of 12 articles: HTML format

Single Articles

July 2025
1. YAMASAKI S, Nakahara T, Tsuge M, Yamaoka K, et al
   Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients.
   J Gastroenterol. 2025 Jul 7. doi: 10.1007/s00535-025-02270.
   PubMed     Abstract available
   
   
   
2. SUZUKI T, Matsuura K, Tahata Y, Hikita H, et al
   Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy.
   J Gastroenterol. 2025 Jul 1. doi: 10.1007/s00535-025-02282.
   PubMed     Abstract available
   
   
   June 2025
3. KAWAGISHI N, Suda G, Tahata Y, Hikita H, et al
   Pretreatment serum angiopoietin-2 predicts prognosis and liver functional reserve after successful HCV eradication with sofosbuvir and velpatasvir in patients with HCV-related decompensated cirrhosis.
   J Gastroenterol. 2025 Jun 20. doi: 10.1007/s00535-025-02275.
   PubMed     Abstract available
   
   
   February 2025
4. WATANABE T, Tokumoto Y, Ochi H, Mashiba T, et al
   Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy.
   J Gastroenterol. 2025;60:222-234.
   PubMed     Abstract available
   
   
   November 2024
5. IWAMOTO T, Nozaki Y, Inoue T, Suda T, et al
   Histological improvement of fibrosis in patients with hepatitis C who achieved a 5-year sustained virological response to treatment with direct-acting antivirals.
   J Gastroenterol. 2024 Nov 25. doi: 10.1007/s00535-024-02165.
   PubMed     Abstract available
   
   
   September 2024
6. YAMAUCHI K, Maekawa S, Osawa L, Komiyama Y, et al
   Single-molecule sequencing of the whole HCV genome revealed envelope deletions in decompensated cirrhosis associated with NS2 and NS5A mutations.
   J Gastroenterol. 2024 Sep 3. doi: 10.1007/s00535-024-02146.
   PubMed     Abstract available
   
   
   May 2024
7. SUZUKI T, Matsuura K, Nagura Y, Ito K, et al
   MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.
   J Gastroenterol. 2024 May 13. doi: 10.1007/s00535-024-02115.
   PubMed     Abstract available
   
   
   
8. ATSUKAWA M, Tsubota A, Kondo C, Toyoda H, et al
   ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis.
   J Gastroenterol. 2024 May 10. doi: 10.1007/s00535-024-02109.
   PubMed     Abstract available
   
   
   April 2024
9. LIU CH, Chang YP, Fang YJ, Cheng PN, et al
   Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals.
   J Gastroenterol. 2024 Apr 13. doi: 10.1007/s00535-024-02101.
   PubMed     Abstract available
   
   
   December 2023
10. UOJIMA H, Nakabayashi K, Yamasaki K, Sugiyama M, et al
    New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease.
    J Gastroenterol. 2023;58:1252-1260.
    PubMed     Abstract available
    
    
    October 2023
11. TAHATA Y, Hikita H, Mochida S, Enomoto N, et al
    Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus.
    J Gastroenterol. 2023 Oct 13. doi: 10.1007/s00535-023-02039.
    PubMed     Abstract available
    
    
    March 2023
12. SHIMAKAMI T, Setoyama H, Oza N, Itakura J, et al
    Development of performance indicators for hepatitis countermeasures as a tool for the assessment and promotion of liver cancer prevention in Japan.
    J Gastroenterol. 2023;58:257-267.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.